Characterization of diverse viral vector preparations, using a simple and rapid whole-virion dot-blot method

Human Gene Therapy

Volumn 9, Issue 16, 1998, Pages 2401-2405

  Nelson, David M ^a,b   Jarmo Wahlfors, J ^a   Chen, Lin ^a   Onodera, Masafumi ^a   Morgan, Richard A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b Aurora Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; DNA VIRUS; DOT HYBRIDIZATION; HUMAN; HUMAN CELL; METHODOLOGY; NONHUMAN; RNA VIRUS; VIRION; VIRUS TITRATION;

EID: 17344371391     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.16-2401     Document Type: Article

References (13)

1. BLAKE, K., and O'CONNELL, S. (1993). Virus culture. In Virology Labfax. D.R. Harper, ed. (BIOS Scientific Publishers, Oxford) pp. 81-122.
2. FROLOV, I., HOFFMAN, T.A., PRAGAI, B.M., DRYGA, S.A., HUANG, H.V., SCHLESINGER, S., and RICE, C.M. (1996). Alphavirus-based expression vectors-strategies and applications. Proc. Natl. Acad. Sci. U.S.A. 93, 11371-11377.
3. GORDON, E.M., and ANDERSON, W.F. (1994). Gene therapy using retroviral vectors. Curr. Opin. Biotechnol. 5, 611-616.
4. HUSZAR, D., ELLIS, J., and BERNSTIEN, A. (1989). A rapid and accurate method for determining the titer of a retrovirus lacking a selectable marker. Technique-J. Methods Cell Mol. Biol. 1, 28-32.
5. LOZIER, J.N., YANKASKAS, J.R., RAMSEY, W.J., CHEN, L., BERSCHNEIDER, H., and MORGAN, R.A. (1997). Gut epithelial-cells as targets for gene-therapy of hemophilia. Hum. Gene Ther. 8, 1481-1490.
6. LUNDSTROM, K. (1997). Alphaviruses as expression vectors. Curr. Opin. Biotechnol. 8, 578-582.
7. MURDOCH, B., PEREIRA, D.S., WU, X., DICK, J.E., and ELLIS, J. (1997). A rapid screening-procedure for the identification of high-titer retrovirus clones. Gene Ther. 4, 744-749.
8. NYBERGHOFFMAN, C., SHABRAM, P., LI, W., GIROUX, D., and AGUILARCORDOVA, E. (1997). Sensitivity and reproducibility in adenoviral infectious titer determination. Nature Med. 3, 808-811.
9. ONODERA, M., YACHIE, A., NELSON, D.M., WELCHLIN, H., MORGAN, R.A., and BLAESE, R.M. (1997). A simple and reliable method for screening retroviral producer clones without selectable markers. Hum. Gene Ther. 8, 1189-1194.
10. QUINN, T.P., and TREVOR, K.T. (1997). Rapid quantitation of recombinant retrovirus produced by packaging cell clones. Biotechniques 23, 1038-1044.
11. SHENK, T. (1995). Group C adenoviruses as vectors for gene therapy. In Viral Vectors: Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, San Diego, CA) pp. 43-54.
12. STRAYER, D.S. (1996). SV40 as an effective gene transfer vector in vivo. J. Biol. Chem. 271, 24741-24746.
13. WANG, Q., JIA, X.C., and FINER, M.H. (1995). A packaging cell-line for propagation of recombinant adenovirus vectors containing 2 lethal gene-region deletions. Gene Ther. 2, 775-783.